
ThinkBio.Ai is an AI-powered healthcare and life sciences solutions company, transforming complex data into actionable insights for better, faster decision-making.
ThinkBio.Ai, Inc has raised $20.0M in total funding. The most recent round was Series A.
ThinkBio.Ai, Inc is headquartered in Ontario, CA.
ThinkBio.Ai is an AI-powered healthcare and life sciences solutions company, transforming complex data into actionable insights for better, faster decision-making.
Biological intelligence is fragmented -- clinical, molecular, and real-world evidence sit in disconnected systems, making biological signals computationally inaccessible and slowing drug development decisions.
ThinkBio.Ai builds proprietary AI platforms and knowledge graphs that turn complex biomedical data into actionable scientific and clinical intelligence for healthcare and life sciences organizations.
It cites a knowledge graph with 250 million relationships, multi-omic AI reasoning engines, predictive toxicity and efficacy models, and a named pipeline (DrugSuccess.Ai) referenced in a client testimonial.
ThinkBio.Ai was co-founded by Sam Santhosh, who previously founded MedGenome, India's leading genomics diagnostics company, and was named to Goldman Sachs' Top 100 list in 2019.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.